DUBLIN--(BUSINESS WIRE)--The "Clostridium Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Clostridium Diagnostics Market to Reach US$4.7 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for Clostridium Diagnostics estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at a CAGR of 13.9% over the period 2020-2027.
Immunoassays, one of the segments analyzed in the report, is projected to grow at a 15.4% CAGR to reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular Diagnostics segment is readjusted to a revised 9.5% CAGR for the next 7-year period. This segment currently accounts for a 28.8% share of the global Clostridium Diagnostics market.
The U. S. Accounts for Over 26.9% of Global Market Size in 2020, While China is Forecast to Grow at a 18.4% CAGR for the Period of 2020-2027
The Clostridium Diagnostics market in the U. S. is estimated at US$512.3 Million in the year 2020. The country currently accounts for a 26.94% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.1 Billion in the year 2027 trailing a CAGR of 18.4% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.6% and 12.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR while Rest of European market (as defined in the study) will reach US$1.1 Billion by the year 2027.
The publisher brings years of research experience to this 9th edition of the report. The 378-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Chrono-log Corporation
- Corgenix
- Diazyme Laboratories
- F. Hoffmann-La Roche AG
- Fujirebio US, Inc.
- Hologic, Inc.
- QIAGEN GmbH
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
Key Topics Covered
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Clostridium Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Impact of COVID-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 42
For more information about this report visit https://www.researchandmarkets.com/r/31mswt
